| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 吡啶类(元) | 472,018,972.78 | 196,538,788.24 | 393,429,083.62 | 214,055,795.67 |
| 非吡啶类(元) | 48,980,537.24 | 26,001,386.07 | 49,578,872.88 | 30,172,838.94 |
| 营业成本(元) | ||||
| 吡啶类(元) | 407,955,930.79 | 171,903,640.37 | 362,497,959.19 | 201,162,622.57 |
| 非吡啶类(元) | 47,018,967.25 | 21,943,618.90 | 38,686,441.48 | 23,345,993.19 |
| 毛利(元) | ||||
| 吡啶类(元) | 64,063,041.99 | 24,635,147.87 | 30,931,124.43 | 12,893,173.10 |
| 非吡啶类(元) | 1,961,569.99 | 4,057,767.17 | 10,892,431.40 | 6,826,845.75 |
| 毛利率(%) | ||||
| 吡啶类(%) | 13.57 | 12.53 | 7.86 | 6.02 |
| 非吡啶类(%) | 4.00 | 15.61 | 21.97 | 22.63 |
| 收入构成(%) | ||||
| 吡啶类(%) | 90.60 | 88.32 | 88.81 | 87.65 |
| 非吡啶类(%) | 9.40 | 11.68 | 11.19 | 12.35 |
| 毛利构成(%) | ||||
| 吡啶类(%) | 97.03 | 85.86 | 73.96 | 65.38 |
| 非吡啶类(%) | 2.97 | 14.14 | 26.04 | 34.62 |